Physician profile
Gary B Buck
NPI 1427054253
$2,241.76
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,318 · 2020: $191 · 2021: $239 · 2022: $78.65 · 2023: $36.03 · 2024: $379.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $379 · Food and Beverage: $36.03.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $379.17 |
| Food and Beverage | $36.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $379.17 | 2024 | |
| Abbott Laboratories | $339.57 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $185.76 | 2019-2020 | |
| Mdd US Operations, LLC | $181.90 | 2019-2020 | |
| Daiichi Sankyo INC. | $170.84 | 2019 | |
| Biodelivery Sciences International, INC. | $160.50 | 2019-2021 | |
| Medtronic USA, INC. | $111.11 | 2019 | |
| Boston Scientific Corporation | $102.29 | 2019-2022 | |
| Collegium Pharmaceutical, INC. | $86.45 | 2019-2021 | |
| Nevro Corp. | $70.50 | 2019 | |
| Scilex Pharmaceuticals INC. | $68.03 | 2019-2021 | |
| Zyla Life Sciences, INC. | $42.56 | 2019-2020 | |
| Pfizer INC. | $41.23 | 2019-2021 | |
| Arbor Pharmaceuticals, INC. | $39.19 | 2019-2020 | |
| Sentynl Therapeutics, INC. | $38.20 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conmed Corporation | $36.81 | 2022-2023 | Abc Handpieces, Airseal |
| Si-Bone, INC. | $34.95 | 2019-2020 | |
| Forte Bio-Pharma LLC | $27.72 | 2019-2020 | |
| Horizon Therapeutics Plc | $25.83 | 2019-2020 | |
| Uswm, LLC | $25.82 | 2021 | |
| Janssen Biotech, INC. | $17.52 | 2023 | Stelara |
| Kaleo, INC. | $14.93 | 2019 | |
| Pernix Therapeutics Holdings, INC. | $14.81 | 2019 | |
| Almatica Pharma LLC | $13.87 | 2021 | |
| Virtus Pharmaceuticals LLC | $12.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Buck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.